Big Techs and startups in pharmaceutical R&D – A 2020 perspective on artificial intelligence
Journal
Drug Discovery Today
ISSN
1359-6446
Type
journal article
Date Issued
2021
Author(s)
Abstract (De)
We investigated what kind of artificial intelligence (AI) technologies are utilized in pharmaceutical
research and development (R&D) and which sources of AI-related competencies can be leveraged by
pharmaceutical companies. First, we found that machine learning (ML) is the dominating AI
technology currently used in pharmaceutical R&D. Second, both Big Techs and AI startups are
competent knowledge bases for AI applications. Big Techs have long-lasting experience in the digital
field and offer more general IT solutions to support pharmaceutical companies in cloud computing,
health monitoring, diagnostics or clinical trial management, whereas startups can provide more
specific AI services to address special issues in the drug-discovery space.
research and development (R&D) and which sources of AI-related competencies can be leveraged by
pharmaceutical companies. First, we found that machine learning (ML) is the dominating AI
technology currently used in pharmaceutical R&D. Second, both Big Techs and AI startups are
competent knowledge bases for AI applications. Big Techs have long-lasting experience in the digital
field and offer more general IT solutions to support pharmaceutical companies in cloud computing,
health monitoring, diagnostics or clinical trial management, whereas startups can provide more
specific AI services to address special issues in the drug-discovery space.
Language
English
HSG Classification
contribution to scientific community
HSG Profile Area
SoM - Business Innovation
Refereed
Yes
Publisher
Elsevier Science
Subject(s)
Division(s)
Eprints ID
263556